Antiphosphatidylserine/prothrombin antibodies (aPS/PT) and risk of obstetric anti-phospholipid syndrome.

Zhang, Xiaoxin; Liu, Zhilan; Guo, Feng; Wang, Qiaohong; Bai, Wenxin; Zhao, Aimin

Zhang, Xiaoxin; Liu, Zhilan; Guo, Feng; Wang, Qiaohong; Bai, Wenxin; Zhao, Aimin.

Afiliación

Zhang X; Department of Obstetrics and Gynecology, School of Medicine, Renji Hospital, Shanghai Jiaotong University, Shanghai, China.
Liu Z; Shanghai Key Laboratory of Gynecologic Oncology, Shanghai, China.
Guo F; Department of Obstetrics and Gynecology, School of Medicine, Renji Hospital, Shanghai Jiaotong University, Shanghai, China.
Wang Q; Shanghai Key Laboratory of Gynecologic Oncology, Shanghai, China.
Bai W; Department of Obstetrics and Gynecology, School of Medicine, Renji Hospital, Shanghai Jiaotong University, Shanghai, China.
Zhao A; Department of Obstetrics and Gynecology, School of Medicine, Renji Hospital, Shanghai Jiaotong University, Shanghai, China.

Am J Reprod Immunol ; 89(6): e13621, 2023 06.

Article en En | MEDLINE | ID: mdl-36181461

Asunto(s)

Síndrome Antifosfolípido; Embarazo; Humanos; Femenino; Síndrome Antifosfolípido/epidemiología; Síndrome Antifosfolípido/diagnóstico; Anticuerpos Antifosfolípidos; Protrombina; Estudios Retrospectivos; China/epidemiología; Inmunoglobulina G; Fosfatidilserinas; Inmunoglobulina M

Palabras clave

antiphosphatidylserine/prothrombin; obstetric anti-phospholipid syndrome; pregnancy morbidities; seronegative antiphospholipid syndrome; thrombosis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Síndrome Antifosfolípido Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Pregnancy País/Región como asunto: Asia Idioma: En Revista: Am J Reprod Immunol Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google